Toggle visibility Search & Display Options

Select All    Deselect All
 | 
Citations
 | 
   print
Westermeyer, R. W. (1990). Push harm reduction. Robert Westermeyer.
Toggle visibility
Moresi, R. (2006, 10.08.2006). Drogensituation spitzt sich zu : zwei neue Spritzen-Attacken. 20 Minuten, 1.
Toggle visibility
Kerr, T. (2000). Safe injection facilities : proposal for a Vancouver pilot project. Vancouver: Harm Reduction Action Society.
Toggle visibility
International Harm Reduction Development Program. (2004). Harm reduction : questions and answers. New York: Open Society Institute (OSI).
Toggle visibility
Office fédéral de la santé publique. (2003). Traitement avec prescription d'héroïne (HeGeBe) en 2002. Berne: Office fédéral de la santé publique (OFSP).
Toggle visibility
Icard, C., Chossegros, P., & Barlet, P. (2001). Comment vit-on l'hépatite C en prison? THS : la revue des addictions : publication trimestrielle de la SETHS (Société européenne toxicomanies, hépatites, sida), 3(12; 12/2001), 681–683.
Toggle visibility
Junius, J. (2003). The aging of HIV (fact sheet) (E. P. Tomaszewski, Ed.). Washington: National Association of Social Workers (NASW).
Toggle visibility
Holmberg, M. (1998, 18.12.1998). Ecstasy can cause irreversible brain damage. Dagens Nyheter, 2.
Toggle visibility
Hunt, N., Ashton, M., Lenton, S., Mitcheson, L., Nelles, B., & Stimson, G. (2003). A review of the evidence-base for harm reduction approaches to drug use. London: Forward Thinking on Drugs.
Toggle visibility
UK Hepatitis C Resource Centre. (2004). Hepatitis C information pack. Glasgow: Mainliners, UK Hepatitis C Resource Centre.
Toggle visibility
Select All    Deselect All
 | 
Citations
 | 
   print